Stocks · News reference
Faes Farma Reports 9M 2026 Financial Results
Faes Farma announced a 24% increase in 9M revenue and reaffirmed its full-year 2026 guidance as international growth and the integration of SIFI offset losses from bilastine in Japan.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- fiscal.ai
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
No Linked Headlines Yet
The feed will populate when a captured headline is linked to this market.